Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Effect of anions or foods on absolute bioavailability of calcium from calcium salts in mice by pharmacokinetics.

Ueda Y, Taira Z.

J Exp Pharmacol. 2013 Oct 15;5:65-71. doi: 10.2147/JEP.S49668. eCollection 2013.

2.

Calcium revisited, part III: effect of dietary calcium on BMD and fracture risk.

Burckhardt P.

Bonekey Rep. 2015 Aug 5;4:708. doi: 10.1038/bonekey.2015.77. eCollection 2015. Review.

3.

The therapeutic effectiveness of the coadministration of weekly risedronate and proton pump inhibitor in osteoporosis treatment.

Tanaka M, Itoh S, Yoshioka T, Yamashita K.

J Osteoporos. 2014;2014:607145. doi: 10.1155/2014/607145. Epub 2014 Nov 9.

4.

Calcium revisited: part II calcium supplements and their effects.

Lamy O, Burckhardt P.

Bonekey Rep. 2014 Oct 8;3:579. doi: 10.1038/bonekey.2014.74. eCollection 2014. Review.

5.

Chronic proton pump inihibitor therapy and calcium metabolism.

Yang YX.

Curr Gastroenterol Rep. 2012 Dec;14(6):473-9. doi: 10.1007/s11894-012-0290-4. Review.

7.

Use of proton pump inhibitors and risk of osteoporosis-related fractures.

Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD.

CMAJ. 2008 Aug 12;179(4):319-26. doi: 10.1503/cmaj.071330.

8.

Evaluation of quick disintegrating calcium carbonate tablets.

Fausett H, Gayser C Jr, Dash AK.

AAPS PharmSciTech. 2000 Jul 2;1(3):E20.

9.
10.

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.

Sheikh MS, Maguire JA, Emmett M, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS.

J Clin Invest. 1989 Jan;83(1):66-73.

11.
12.

Importance of the stomach in maintaining calcium homoeostasis in the rat.

Axelson J, Persson P, Gagnemo-Persson R, HÃ¥kanson R.

Gut. 1991 Nov;32(11):1298-302.

Supplemental Content

Support Center